US Patent Issued to Biogen MA, Samsung Bioepis on Oct. 14 for "Methods for overcoming glutamine deprivation during mammalian cell culture" (American, South Korean Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,980, issued on Oct. 14, was assigned to Biogen MA Inc. (Cambridge, Mass.) and Samsung Bioepis (Yeonsu-gu, South Korea).

"Methods for overcoming glutamine deprivation during mammalian cell culture" was invented by William C. Yang (Cary, N.C.), Yao-Ming Huang (Cary, N.C.), Marty Sinacore (Andover, Mass.), Thomas Ryll (Weston, Mass.), Jiuyi Lu (Ipswich, Mass.), Jaesun Lee (Incheon, South Korea), Kyngju Lee (Incheon, South Korea), Hyoung Taek Lim (Incheon, South Korea) and Eunchong Yang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to methods of producing polypeptide of interest in cell cultures lackin...